Recent Advances in Soft Tissue Tumor Pathology: Evolving Classification, Novel Molecular Findings and New Diagnostic Markers

Recent Advances in Soft Tissue Tumor Pathology: Evolving Classification, Novel Molecular Findings and New Diagnostic Markers is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Dec 06 - 07, 2018 at USCAP West, Palm Springs, California, United States of America. This CME Conference has been approved for a maximum of 15 AMA PRA Category 1 Credits.

Course Description:
The diagnosis of soft tissue tumors can be a significant challenge (even for experienced pathologists) because of their rarity, the broad morphological spectrum of mesenchymal tumors, and overlap with other soft tissue tumors and non-mesenchymal neoplasms. The classification of soft tissue tumors continues to evolve, following the description of “new” tumor types, the discovery of novel molecular genetic alterations, and the development of increasingly specific diagnostic immunohistochemical markers. If your specialty interest is in soft tissue pathology, or if your practice requires enhanced competency in evaluating soft tissue lesions, this course is designed to familiarize you with recently-described soft tissue tumors and recently-developed diagnostic markers.

Course Objectives:
• Develop a differential diagnosis for soft tissue tumors based on dominant histologic patterns and anatomic sites
• Apply immunohistochemistry to help resolve the differential diagnosis
• Understand the role of molecular genetic testing for the diagnosis of soft tissue tumors

Additional details will be posted as soon as they are available.